Table 1.
Summary of reported cases, possible vertical transmission and patient’s treatment
| Chen H et al. (2020)11 | Nan Yu et al. (2020)27 | Zhu H et al. (2020)28 | Breslin N et al. (2020) 29 | Dong L et al. (2020)30 | Zeng H et al. (2020)31 | |
|---|---|---|---|---|---|---|
| Number of infected women with COVID-19 | 9 (100%) | 7 (100%) | 9 | 18 | 1 | 6 |
| Number of born neonates | 9 (100%) | 7 (100%) | 10 | 18 | 1 | 6 |
| Cesarean section delivery | 9 (100%) | 7 (100%) | 7 | 9 | 1 | 6 |
| Vaginal Delivery | 0 | 0 | 3 | 9 | NA | NA |
| Number of tested neonates for COVID-19 PCR | 9 | 3 | 10 | 18 | 1 | 6 |
| Nasopharyngeal swab positive for COVID-19 neonates | 0 | 1 | 0 | 0 | 0 | 0 |
| COVID-19 IgG positive neonates | 0 | NA | NA | 0 | 1 | 5 |
| COVID-19 IgM positive neonates | 0 | NA | NA | 0 | 1 | 2 |
| Breastmilk samples positive for COVID—19 | 0 | NA | NA | NA | NA | NA |
| Vertical transmission | No | Yes | No | No | Yes | Yes |
| Oxygen support | 9 (100%) | 7 (100%) | – | 1 (2%) | 1 (100%) | – |
| Antiviral therapy | 6 (67%) | 7 (100%) | 5 (56%) | – | 1 (100%) | – |
| Antibiotic therapy | 9 (100%) | 7 (100%) | – | 2 (5%) | 1 (100%) | – |
| Hydroxychloroquine | – | – | – | 2 (5%) | – | – |
| Corticosteroid treatment | 0 | 5 (71%) | – | – | 1 (100%) | – |
| Interferon | 0 | 7 (100%) | 1 (11%) | – | – | – |
| Chinese medicine | 0 | 7 (100%) | – | – | – | – |
*PCR polymerase chain reaction